Assenagon Asset Management S.A. grew its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 277.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 878,894 shares of the health services provider's stock after buying an additional 645,760 shares during the period. Assenagon Asset Management S.A. owned 1.45% of Maximus worth $81,878,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in MMS. V Square Quantitative Management LLC purchased a new position in shares of Maximus during the 3rd quarter valued at about $25,000. GAMMA Investing LLC grew its stake in shares of Maximus by 224.5% during the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock worth $29,000 after purchasing an additional 238 shares during the period. Blue Trust Inc. increased its holdings in shares of Maximus by 201.5% during the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider's stock valued at $33,000 after purchasing an additional 262 shares in the last quarter. Archer Investment Corp lifted its stake in shares of Maximus by 8,788.9% in the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider's stock valued at $69,000 after purchasing an additional 791 shares during the period. Finally, Ariadne Wealth Management LP purchased a new stake in Maximus during the second quarter worth $90,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Maximus
In other news, insider Michelle F. Link sold 1,363 shares of the company's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares of the company's stock, valued at $607,841.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.40% of the stock is currently owned by insiders.
Maximus Stock Performance
MMS traded up $0.49 on Thursday, reaching $87.48. The stock had a trading volume of 256,342 shares, compared to its average volume of 345,991. The business's 50-day moving average price is $90.06 and its two-hundred day moving average price is $87.35. The company has a market cap of $5.32 billion, a P/E ratio of 22.96 and a beta of 0.76. Maximus, Inc. has a 12-month low of $72.81 and a 12-month high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.47 by $0.27. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The firm had revenue of $1.31 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter last year, the company earned $0.78 EPS. The firm's revenue for the quarter was up 10.6% compared to the same quarter last year. Sell-side analysts forecast that Maximus, Inc. will post 6.12 earnings per share for the current year.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.37%. The ex-dividend date of this dividend is Friday, November 15th. Maximus's payout ratio is 31.50%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.